Year None20212020201920182017 NEWS RELEASE 02.26.2021 Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma NEWS RELEASE 02.24.2021 Amgen To Present At The Cowen 41st Annual Healthcare Conference NEWS RELEASE 02.22.2021 Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting NEWS RELEASE 02.22.2021 Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis NEWS RELEASE 02.16.2021 FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer NEWS RELEASE 02.09.2021 Amgen To Present At Guggenheim Healthcare Talks Oncology Day NEWS RELEASE 02.03.2021 Amgen Sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to Help Accelerate Life Science Startups NEWS RELEASE 02.02.2021 Amgen Reports Fourth Quarter And Full Year 2020 Financial Results NEWS RELEASE 01.29.2021 Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China NEWS RELEASE 01.28.2021 Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results NEWS RELEASE 01.28.2021 Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer NEWS RELEASE 01.26.2021 Amgen To Webcast Investor Meeting At 2020 World Conference on Lung Cancer NEWS RELEASE 01.12.2021 Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 NEWS RELEASE 01.11.2021 Amgen To Achieve Carbon Neutrality By 2027 NEWS RELEASE 01.06.2021 Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference